Review: The neurobiology of varicella zoster virus infection

Neuropathology and Applied Neurobiology

Volumn 37, Issue 5, 2011, Pages 441-463

  Gilden, Don ^a   Mahalingam, R ^a   Nagel, M A ^a   Pugazhenthi, S ^a,b   Cohrs, R J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Animal model; Apoptosis; Latency; Neurological disease; VZV

Indexed keywords

VARICELLA ZOSTER VACCINE;

APOPTOSIS; CELL DEATH; CEREBELLUM DISEASE; EYE DISEASE; HAPLORHINI; HERPES ZOSTER; HUMAN; KNOWLEDGE; MENINGITIS; MENINGOENCEPHALITIS; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RETINA NECROSIS; REVIEW; SPINAL CORD DISEASE; VARICELLA ZOSTER VIRUS; VASCULAR DISEASE; VIROLOGY; VIRUS GENOME; VIRUS IMMUNITY; VIRUS LATENCY; VIRUS REACTIVATION; ZOSTER SINE HERPETE;

ANIMALS; CHICKENPOX; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; NEURALGIA, POSTHERPETIC;

EID: 79960204718     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2011.01167.x     Document Type: Review

References (202)

1. Leppard B, Naburi AE. Herpes zoster: an early manifestation of HIV infection. Afr Health 1998; 21: 5-6.
2. Kakourou T, Theodoridou M, Mostrou G, Syriopoulou V, Papadogeorgaki H, Constantopoulos A. Herpes zoster in children. J Am Acad Dermatol 1998; 39: 207-10.
3. Blumenthal DT, Salzman KL, Baringer JR, Forghani B, Gilden DH. MRI abnormalities in chronic active varicella zoster infection. Neurology 2004; 63: 1538-9.
4. Merchet MP, Gruener G. Segmental zoster paresis of limbs. Electromyogr Clin Neurophysiol 1996; 36: 369-75.
5. Yoleri O, Olmez N, Oztura I, Sengül I, Günaydin R, Memis A. Segmental zoster paresis of the upper extremity: a case report. Arch Phys Med Rehabil 2005; 86: 1492-4.
6. Anderson JP, Keal EE. Cervical herpes zoster and diaphragmatic paralysis. Br J Dis Chest 1969; 63: 222-6.
7. Tjandra J, Mansel RE. Segmental abdominal herpes zoster paresis. Aust NZ J Surg 1986; 56: 807-8.
8. Head H, Campbell AW. The pathology of herpes zoster and its bearing on sensory localization. Brain 1900; 23: 353-523.
9. Denny-Brown D, Adams RD, Fitzgerald PJ. Pathologic features of herpes zoster: a note on 'geniculate herpes'. Arch Neurol Psychiatry 1944; 51: 216-31.
10. Cheatham WJ, Dolan TF Jr, Dower JC, Weller TH. Varicella: report on two fatal cases with necropsy, virus isolation, and serologic studies. Am J Pathol 1956; 32: 1015-35.
11. Esiri MM, Tomlinson AH. Herpes zoster: demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci 1972; 15: 35-48.
12. Ghatak NR, Zimmerman HM. Spinal ganglion in herpes zoster. Arch Pathol 1973; 95: 411-15.
13. Nagashima K, Nakazawa M, Endo H. Pathology of the human spinal ganglia in varicella-zoster virus infection. Acta Neuropathol 1975; 33: 105-17.
14. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004; 72: 174-9.
15. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. Asymptomatic reactivation and shed of infectiousvaricella zoster virus in astronauts. J Med Virol 2008; 80: 1116-22.
16. Rogers RS III, Tindall JP. Herpes zoster in the elderly. Postgrad Med 1971; 50: 153-7.
17. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997; 13: 327-31.
18. Smith FP. Pathological studies of spinal nerve ganglia in relation to intractable intercostal pain. Surg Neurol 1978; 10: 50-3.
19. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Postherpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991; 44: 105-17.
20. Vafai A, Wellish M, Gilden DH. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci USA 1988; 85: 2767-70.
21. Devlin ME, Gilden DH, Mahalingam R, Dueland AN, Cohrs R. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis 1992; 165: 619-22.
22. Mahalingam R, Wellish M, Brucklier J, Gilden DH. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995; 1: 130-3.
23. Terada K, Niizuma T, Kawano S, Kataoka N, Akisada T, Orita Y. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol 1998; 56: 359-63.
24. Gilden DH, Cohrs RJ, Hayward AR, Wellish M, Mahalingam R. Chronic varicella zoster virus ganglionitis - a possible cause of postherpetic neuralgia. J Neurovirol 2003; 9: 404-7.
25. Quan D, Hammack BN, Kittelson J, Gilden DH. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol 2006; 63: 940-2.
26. Nagel MA, Cohrs RJ, Mahalingam R, Wellish MC, Forghani F, Schiller A, Safdieh JE, Kamenkovich E, Ostrow LW, Levy M, Greenberg B, Russman AN, Katzan I, Gardner CJ, Häusler M, Nau R, Saraya T, Wada H, Goto H, de Martino M, Ueno M, Brown WD, Terborg C, Gilden DH. The varicella zoster vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008; 70: 853-60.
27. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007; 68: 1069-73.
28. Burgoon MP, Hammack BN, Owens GP, Maybach AL, Eikelenboom MJ, Gilden DH. Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus(VZV) vasculopathy are directed against VZV. Ann Neurol 2003; 54: 459-63.
29. Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009; 40: 3443-8.
30. Lin H-C, Chien C-W, Ho J-D. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010; 74: 792-7.
31. Gilden DR, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 1996; 47: 1441-6.
32. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001; 125: 770-80.
33. Salazar R, Russman AN, Nagel MA, Cohrs RJ, Mahalingam R, Schmid DS, Kleinschmidt-DeMasters BK, VanEgmond EM, Gilden D. VZV ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol 2011; 68: 517-20.
34. Mayberg MR, Langer RS, Zervas NT, Moskowitz MA. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981; 213: 228-30.
35. Mayberg MR, Zervas NT, Moscowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984; 223: 46-56.
36. Lee RM. Morphology of cerebral arteries. Pharmacol Ther 1995; 66: 149-73.
37. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci 2002; 195: 99-101.
38. Habib AA, Gilden D, Schmid DS, Safdieh JE. Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash and in an immunocompetent woman. J Neurovirol 2009; 15: 206-8.
39. Klein NC, McDermott B, Cunha BA. Varicella-zoster virus meningoencephalitis in an immunocompetent patient without a rash. Scand J Infect Dis 2010; 42: 631-3.
40. Gunson RN, Aitken C, Gilden D. A woman with acute headache and sacral dermatomal numbness. J Clin Virol 2011; 50: 191-3.
41. Moses H, Nagel MA, Gilden DH. Acute cerebellar ataxia in a 41 year old woman. Lancet Neurol 2006; 5: 984-8.
42. Ratzka P, Schlachetzki JC, Bähr M, Nau R. Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster. Lancet 2006; 367: 182.
43. Pina MA, Ara JR, Capablo JL, Omeñaca M. Myelitis and optic neuritis caused by varicella. Rev Neurol 1997; 25: 1575-6.
44. Celik Y, Tabak F, Mert A, Celik AD, Aktuǧlu Y. Transverse myelitis caused by varicella. Clin Neurol Neurosurg 2001; 103: 260-1.
45. Gilden DH, Beinlich BR, Rubinstien EM, Stommel E, Swenson R, Rubinstein D, Mahalingam R. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 1994; 44: 1818-23.
46. Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain 1991; 114: 1181-96.
47. de Silva SM, Mark AS, Gilden DH, Mahalingam R, Balish M, Sandbrink F, Houff S. Zoster myelitis: improvement with antiviral therapy in two cases. Neurology 1996; 47: 929-31.
48. Chua HC, Tjia H, Sitoh YY. Concurrent myelitis and Guillain-Barre syndrome after varicella infection. Int J Clin Pract 2001; 55: 643-4.
49. Schvoerer E, Frechin V, Warter A, Gasser B, Jouin H, Gut JP, Stoll-Keller F. Persistent multiple pulmonary nodules in a nonimmunocompromised woman after varicella-related myelitis treated with acyclovir. J Clin Microbiol 2003; 41: 4904-5.
50. Orme HT, Smith G, Nagel MA, Bert RJ, Mickelson TS, Gilden DH. VZV spinal cord infarction identified by diffusion-weighted magnetic resonance imaging (DWI). Neurology 2007; 69: 398-400.
51. Bonfioli AA, Eller AW. Acute retinal necrosis. Semin Ophthalmol 2005; 20: 155-60.
52. Guex-Crosier Y, Rochat C, Herbort CP. Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm 1997; 5: 259-65.
53. Lewis JM, Nagae Y, Tano Y. Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol 1996; 122: 892-5.
54. Franco-Paredes C, Bellehemeur T, Merchant A, Sanghi P, DiazGranados C, Rimland D. Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS 2002; 16: 1045-9.
55. Menerath JM, Gerard M, Laurichesse H, Goldschmidt P, Peigue-Lafeuille H, Rozenberg F, Beytout J. Bilateral acute retinal necrosis in a patient with acquired immunodeficiency syndrome. J Fr Ophtalmol 1995; 18: 625-33.
56. Johnston WH, Holland GN, Engstrom RE Jr, Rimmer S. Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993; 116: 42-50.
57. Moorthy RS, Weinberg DV, Teich SA, Berger BB, Mintum JT, Kumar S, Rao NA, Fowell SM, Loose IA, Jampol LM. Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol 1997; 81: 189-94.
58. Austin RB. Progressive outer retinal necrosis syndrome: a comprehensive review of its clinical presentation, relationship to immune system status, and management. Clin Eye Vis Care 2000; 12: 119-29.
59. Lewis GW. Zoster sine herpete. Br Med J 1958; 2: 418-21.
60. Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994; 35: 530-3.
61. Amlie-Lefond C, Mackin GA, Ferguson M, Wright RR, Mahalingam R, Gilden DH. Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol 1996; 2: 136-8.
62. Blumenthal DT, Shacham-Shmueli E, Bokstein F, Schmid DS, Cohrs RJ, Nagel MA, Mahalingam R, Gilden D. Zoster sine herpete: virological verification by detection of anti-VZV IgG antibody in CSF. Neurology 2011; 76: 484-5.
63. Hevner RF, Vilela MD, Rostomily RC, Cohrs RJ, Mahalingam R, Wellish M, Gilden DH. An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol 2003; 2: 567-72.
64. Haug A, Mahalingam R, Cohrs RJ, Schmid DS, Corboy JR, Gilden D. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system. J Neurol Sci 2010; 292: 85-8.
65. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67: 1759-816.
66. Preston VG, Kennard J, Rixon FJ, Logan AJ, Mansfield RW, McDougall IM. Efficient herpes simplex virus type 1 (HSV-1) capsid formation directed by the varicella-zoster virus scaffolding protein requires the carboxy-terminal sequences from the HSV-1 homologue. J Gen Virol 1997; 78: 1633-46.
67. Ross J, Williams M, Cohen JI. Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology 1997; 234: 186-95.
68. Kemble GW, Annuziato P, Lungu O, Winter RE, Cha TA, Silverstein SJ, Spaete RR. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol 2000; 74: 11311-21.
69. Liu M, Vafai N, Liu A, Hart J, Liu H, He J, Tang X, Wang D, Vafai A. Stability of varicella-zoster virus open reading frame 63. Arch Virol 2008; 153:1943-7.
70. Hawrami K, Harper D, Breuer J. Typing of varicella zoster virus by amplification of DNA polymorphisms. J Virol Methods 1996; 57: 169-74.
71. Breuer J. VZV molecular epidemiology. Curr Top Microbiol Immunol 2010; 342: 15-42.
72. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001; 75: 4878-88.
73. Morrow G, Slobedman B, Cunningham AL, Abendroth A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol 2003; 77: 4950-9.
74. Taylor SL, Moffat JF. Replication of varicella-zoster virus in human skin organ culture. J Virol 2005; 79: 11501-6.
75. Desloges N, Schubert C, Wolff MH, Rahaus M. Varicella-zoster virus infection induces the secretion of interleukin-8. Med Microbiol Immunol 2008; 197: 277-84.
76. Huch JH, Cunningham AL, Arvin AM, Nasr N, Santegoets SJ, Slobedman E, Slobedman B, Abendroth A. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol 2010; 84: 4060-72.
77. Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci USA 2000; 97: 8146-50.
78. Antinone SE, Smith GA. Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J Virol 2010; 84: 1504-12.
79. Gilden DH, Vafai A, Shtram Y, Becker Y, Devlin M, Wellish M. Varicella-zoster virus DNA in human sensory ganglia. Nature 1983; 306: 478-80.
80. Mahalingam R, Wellish MC, Dueland AN, Cohrs RJ, Gilden DH. Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol 1992; 31: 444-8.
81. Richter ER, Dias JK, Gilbert JE, Atherton SS. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J Infect Dis 2009; 200: 1901-6.
82. Mainka C, Fuss B, Geiger H, Hofelmayr H, Wolff MH. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 1998; 56: 9198.
83. de Jong MD, Weel JF, Schuurman T, Wertheim-van Dillen PM, Boom R. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 2000; 38: 2568-73.
84. Taha Y, Scott FT, Parker SP, Syndercombe Court D, Quinlivan ML, Breuer J. Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual. Clin Infect Dis 2006; 43: 1301-2.
85. Mahalingam R, Wellish M, Soike K, White T, Kleinschmidt-DeMasters BK, Gilden DH. Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology 2001; 279: 339-42.
86. Sadzot-Delvaux C, Thonard P, Schoonbroodt S, Piette J, Rentier B. Varicella-zoster virus induces apoptosis in cell culture. J Gen Virol 1995; 76: 2875-9.
87. Pignata C, Fiore M, de Filippo S, Cavalcanti M, Gaetaniello L, Scotese I. Apoptosis as a mechanism of peripheral blood mononuclear cell death after measles and varicella-zoster virus infections in children. Pediatr Res 1998; 43: 77-83.
88. König A, Hömme C, Hauröder B, Dietrich A, Wolff MH. The varicella-zoster virus induces apoptosis in vitro in subpopulations of primary human peripheral blood mononuclear cells. Microbes Infect 2003; 4: 879-89.
89. Pugazhenthi S, Gilden DH, Nair S, McAdoo A, Wellish M, Brazeau E, Mahalingam R. Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of Bcl-2 expression. J Virol 2009; 83: 9273-82.
90. Brazeau E, Mahalingam R, Gilden D, Wellish M, Kaufer BB, Osterrieder N, Pugazhenthi S. Varicella-zoster virus-induced apoptosis in MeWo cells is accompanied by down-regulation of Bcl-2 expression. J Neurovirol 2010; 16: 133-40.
91. Hood C, Cunningham AL, Slobedman B, Boadle RA, Abendroth A. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J Virol 2003; 77: 12852-64.
92. Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 1983; 2: 814-16.
93. Gilden DH, Rozenman Y, Murray R, Devlin M, Vafai A. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol 1987; 22: 377-80.
94. Kennedy PG, Grinfeld E, Gow JW. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci USA 1998; 95: 4658-62.
95. LaGuardia JJ, Cohrs RJ, Gilden DH. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol 1999; 73: 8571-7.
96. Levin MJ, Cai GY, Manchak MD, Pizer LI. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J Virol 2003; 77: 6979-87.
97. Wang K, Lau TY, Morales M, Mont EK, Straus SE. Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal ganglia at the single-cell level. J Virol 2005; 79: 14079-87.
98. Liedtke W, Opalka B, Zimmermann CW, Lignitz E. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 1993; 116: 6-11.
99. Furuta Y, Takasu T, Fukuda S, Sato-Matsumura KC, Inuyama Y, Hondo R, Nagashima K. Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J Infect Dis 1992; 166: 1157-9.
100. Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol 1999; 73: 10514-18.
101. Cohrs RJ, Randall J, Smith J, Gilden DH, Dabrowski C, van der Keyl H, Tal-Singer R. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000; 74: 11464-71.
102. Hufner K, Derfuss T, Herberger S, Sunami K, Russell S, Sinicina I, Arbusow V, Strupp M, Brandt T, Theil D. Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol 2006; 65: 1022-30.
103. Inoue H, Motani-Saitoh H, Sakurada K, Ikegaya H, Yajima D, Jayakawa M, Sato Y, Otsuka K, Kobayashi K, Nagasawa S, Iwase H. Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1. J Med Virol 2010; 82: 345-9.
104. Mahalingam R, Wellish M, Lederer D, Forghani B, Cohrs R, Gilden DH. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol 1993; 67: 2381-4.
105. Dueland AN, Ranneberg-Nilsen T, Degré M. Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch Virol 1995; 140: 2055-66.
106. Cohrs RJ, Srock K, Barbour MB, Owens G, Mahalingam R, Devlin ME, Wellish M, Gilden DH. Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol 1994; 68: 7900-8.
107. Cohrs RJ, Barbour M, Gilden DH. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in cDNA library enriched for VZV RNA. J Virol 1996; 70: 2789-96.
108. Cohrs RJ, Gilden DH, Kinchington PR, Grinfeld E, Kennedy PGE. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J Virol 2003; 77: 6660-5.
109. Cohrs RJ, Gilden DH. Prevalence and abundance of latently transcribed varicella zoster virus genes in human ganglia. J Virol 2007; 81: 2950-6.
110. Kennedy PGE, Grinfeld E, Bell JE. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol 2000; 74: 11893-8.
111. Sommer SS, Cohen JE. The size distributions of proteins, mRNA, and nuclear RNA. J Mol Evol 1980; 15: 37-57.
112. Vansant G, Pezzoli P, Saiz R, Birch A, Duffy C, Ferre F, Monforte J. Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening. Int J Toxicol 2006; 25: 85-94.
113. Rai AJ, Kamath RM, Gerald W, Fleisher M. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal Bioanal Chem 2009; 393: 1505-11.
114. Nagel MA, Gilden D, Shade T, Gao B, Cohrs RJ. Rapid and sensitive detection of 68 unique varicella zoster virus gene transcripts in five multiplex reverse transcription-polymerase chain reactions. J Virol Methods 2009; 157: 62-8.
115. Nagel MA, Choe A, Traktinskiy I, Cordery-Cotter R, Gilden D, Cohrs RJ. Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol 2011; 85: 2276-8.
116. Stevens JG, Wagner EK, vi-Rao GB, Cook ML, Feldman LT. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056-9.
117. Mahalingam R, Wellish M, Cohrs R, Debrus S, Piette J, Rentier B, Gilden DH. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci USA 1996; 93: 2122-4.
118. Lungu O, Panagiotidis CA, Annunziato PW, Gershon AA, Silverstein SJ. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc Natl Acad Sci USA 1998; 95: 7080-5.
119. Cohrs RJ, Hurley MP, Gilden DH. Array analysis of viral gene transcription during lytic infection of cells in tissue culture with varicella zoster virus. J Virol 2003; 77: 11718-32.
120. Theil D, Derfus T, Paripovic I, Herberger S, Meini E, Schueler O, Strupp M, Arbusow V, Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003; 163: 2179-84.
121. Grinfeld E, Kennedy PG. Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes 2004; 29: 317-19.
122. Zerboni L, Sobel RA, Ramachandran V, Rajamani J, Ruyechan W, Abendroth A, Arvin A. Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia. J Virol 2010; 84: 3421-30.
123. Gary L, Gilden DH, Cohrs RJ. Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia. J Virol 2006; 80: 4921-6.
124. Kubat NJ, Amelio AL, Giordani NV, Bloom DC. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J Virol 2004; 78: 12508-18.
125. Cui C, Griffiths A, Li G, Silva LM, Kramer MF, Gaasterland T, Wang XJ, Coen DM. Prediction and identificationof herpes simplex virus 1-encoded microRNAs. J Virol 2006; 80: 5499-508.
126. Umbach JL, Nagel MA, Cohrs RJ, Gilden DH, Cullen BR. Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol 2009; 83: 10677-83.
127. Umbach JL, Wang K, Tang S, Krause PR, Mont EK, Cohen JI, Cullen BR. Identification of viral microRNAs expressed in human sacral ganglia latently infectedwith herpes simplex virus 2. J Virol 2010; 84: 1189-92.
128. Kumagai T, Chiba Y, Wataya Y, Hanazono H, Chiba S, Nakao T. Development and characteristics of the cellular immune response to infection with varicella-zoster virus. J Infect Dis 1980; 141: 7-13.
129. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986; 154: 422-9.
130. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ. US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009; 200: 1068-77.
131. Good RA, Zak SJ. Disturbances in gamma globulin synthesis as experiments of nature. Pediatrics 1956; 18: 109-49.
132. Gershon AA, Steinberg SP. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections. Infect Immun 1979; 26: 170-4.
133. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, Holmberg SD. Herpes oster and human immunodeficiency virus infection. J Infect Dis 1992; 166: 1153-6.
134. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002; 347: 26-34.
135. Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142: 291-3.
136. Patterson-Bartlett J, Levin MJ, Lang N, Schödel FP, Vessey R, Weinberg A. Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine. Vaccine 2007; 25: 7087-93.
137. Dolin R, Reichman RC, Mazur MH, Whitley RJ. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 1978; 89: 375-88.
138. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84.
139. Verjans GM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus AD. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 2007; 104: 3496-501.
140. Gowrishankar K, Steain M, Cunningham AL, Rodriguez M, Blumbergs P, Slobedman B, Abendroth A. Characterization of the host immune response in human ganglia after herpes zoster. J Virol 2010; 84: 8861-70.
141. Cohen JI. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis 1998; 177: 1390-3.
142. Eisfeld AJ, Yee MB, Erazo A, Abendroth A, Kinchington PR. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J Virol 2007; 81: 9034-49.
143. Steain M, Gowrishankar K, Rodriguez M, Slobedman B, Abendroth A. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella zoster virus infection. J Virol 2010; 85: 626-31.
144. Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis 2003; 182: 40-52.
145. Hayward AR, Zerbe GO, Levin MJ. Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods 1994; 170: 27-36.
146. Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AW. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998; 178 (Suppl. 1): S109-12.
147. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators. Varicella-zoster virus-specific immune responses in elderly recipients of herpes zoster vaccine. J Infect Dis 2008; 197: 825-35.
148. Weinberg A, Levin MJ. VZV T cell-mediated immunity. Curr Top Microbiol Immunol 2010; 342: 341-57.
149. Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1-30.
150. Redman RL, Nader S, Zerboni L, Liu C, Wong RM, Brown BW, Arvin AM. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 1997; 176: 578-85.
151. Lu P-J, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older, in the U.S., 2008. Am J Prev Med 2011; 40: e1-6.
152. Dobson R. Shingles vaccination is likely to be cost effective at age 65 or 70. BMJ 2009; 338: b944.
153. Wroblewska Z, Devlin M, Reilly K, van Trieste H, Wellish M, Gilden DH. The production of varicella zoster virus antiserum in laboratory animals. Arch Virol 1982; 74: 233-8.
154. Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 1995; 69: 3240-5.
155. Myers MG, Duer HL, Hausler CK. Experimental infection of guinea pigs with varicella-zoster virus. J Infect Dis 1980; 142: 414-20.
156. Matsunaga Y, Yamanishi K, Takahashi M. Experimental infection and immune response of guinea pigs with varicella-zoster virus. Infect Immun 1982; 37: 407-12.
157. Walz-Cicconi MA, Rose RM, Dammin GJ, Weller TH. Inoculation of guinea pigs with varicella-zoster virus via the respiratory route. Arch Virol 1986; 88: 265-77.
158. Tenser RB, Hyman RW. Latent herpesvirus infections of neurons in guinea pigs and humans. Yale J Biol Med 1987; 60: 159-67.
159. Lowry PW, Sabella C, Koropchak CM, Watson BN, Thackray HM, Abbruzzi GM, Arvin AM. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. J Infect Dis 1993; 167: 78-83.
160. Wroblewska Z, Valyi-Nagy T, Otte J, Dillner A, Jackson A, Sole DP, Fraser NW. A mouse model for varicella-zoster virus latency. Microb Pathog 1993; 15: 141-51.
161. Sadzot-Delvaux C, Merville-Louis MP, Delree P, Marc P, Piette J, Moonen G, Rentier B. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res 1990; 26: 83-9.
162. Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C. Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 2001; 289: 218-23.
163. Annunziato P, LaRussa P, Lee P, Steinberg S, Lungu O, Gershon AA, Silverstein S. Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J Infect Dis 1998; 178 (Suppl. 1): S48-51.
164. Cohen JI, Moskal T, Shapiro M, Purcell RH. Varicella in chimpanzees. J Med Virol 1996; 50: 289-92.
165. Moffat JF, Stein MD, Kaneshima H, Arvin AM. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 1995; 69: 5236-42.
166. Zerboni L, Ku CC, Jones CD, Zehnder JL, Arvin AM. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci USA 2005; 102: 6490-5.
167. Felsenfeld AD, Schmidt NJ. Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun 1977; 15: 807-12.
168. Padovan D, Cantrell CA. Varicella-like herpesvirus infections of nonhuman primates. Lab Anim Sci 1986; 36: 7-13.
169. Clarke P, Rabkin SD, Inman MV, Mahalingam R, Cohrs R, Wellish M, Gilden DH. Molecular analysis of simian varicella virus DNA. Virology 1992; 190: 597-605.
170. Dueland AN, Martin JR, Devlin ME, Wellish M, Mahalingam R, Cohrs R, Soike KF, Gilden DH. Acute simian varicella infection: clinical, laboratory, pathologic, and virologic features. Lab Invest 1992; 66: 762-73.
171. Gray WL, Starnes B, White MW, Mahalingam R. The DNA sequence of the simian varicella virus genome. Virology 2001; 284: 123-30.
172. Messaoudi I, Barron A, Wellish M, Engelmann F, Legasse A, Planer S, Gilden D, Nikolich-Zugich J, Mahalingam R. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog 2009; 5: e1000657.
173. Sommer MH, Zagha E, Serrano OK, Ku CC, Zerboni L, Baiker A, Santos R, Spengler M, Lynch J, Grose C, Ruyechan W, Hay J, Arvin AM. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol 2001; 75: 8224-39.
174. Cohen JI, Cox E, Pesnicak L, Srinivas S, Krogmann T. The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J Virol 2004; 78: 11833-40.
175. Brazeau E, Wellish M, Kaufer BB, Tischer BK, Gray W, Zhou F, Osterrider N, Hanlon T, Golive A, Hall T, Nair S, Owens GP, Mueller NH, Cohrs JR, Pugazhenthi S, Gilden D, Mahalingam R. Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture. J Neurovirol 2011; 17: 274-80.
176. Clarkson MJ, Thorpe E, McCarthy K. A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus. Arch Gesamte Virusforsch 1967; 22: 219-34.
177. Soike KF, Baskin G, Cantrell C, Gerone P. Investigation of antiviral activity of 1-beta-D-arabinofuranosylthymine (ara-T) and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virus. Antiviral Res 1984; 4: 245-57.
178. Wolf RH, Smetana HF, Allen WP, Felsenfeld AD. Pathology and clinical history of Delta herpesvirus infection in patas monkeys. Lab Anim Sci 1974; 24: 218-21.
179. Roberts ED, Baskin GB, Soike K, Gibson SV. Pathologic changes of experimental simian varicella (Delta herpesvirus) infection in African green monkeys (Cercopithecus aethiops). Am J Vet Res 1984; 45: 523-30.
180. Mahalingam R, Traina-Dorge V, Wellish M, Smith J, Gilden DH. Naturally acquired simian varicella virus infection in African green monkeys. J Virol 2002; 76: 8548-50.
181. Kennedy PGE, Grinfeld E, Traina-Dorge V, Gilden DH, Mahalingam R. Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes 2004; 28: 273-6.
182. Soike KF, Rangan SR, Gerone PJ. Viral disease models in primates. Adv Vet Sci Comp Med 1984; 28: 151-99.
183. Mahalingam R, Messaoudi I, Gilden D. Simian varicella virus pathogenesis. Curr Top Microbiol Immunol 2010; 342: 309-21.
184. Mahalingam R, Traina-Dorge V, Wellish M, Lorino R, Sanford R, Ribka EP, Alleman SJ, Brazeau E, Gilden DH. Simian varicella virus reactivation in Cynomologous monkeys. Virology 2007; 368: 50-9.
185. White TM, Mahalingam R, Traina-Dorge V, Gilden DH. Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J Neurovirol 2002; 8: 191-203.
186. White TM, Mahalingam R, Traina-Dorge V, Gilden DH. Persistence of simian varicella virus DNA in CD4(+) and CD8(+) blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology 2002; 303: 192-8.
187. Mahalingam R, Traina-Dorge V, Wellish M, Deharo E, Singletary ML, Ribka EP, Sanford R, Gilden D. Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol 2010; 16: 342-54.
188. Wenner HA, Abel D, Barrick S, Seshumurty P. Clinical and pathogenetic studies of Medical Lake macaque virus infections in Cynomolgus monkeys (simian varicella). J Infect Dis 1977; 135: 611-22.
189. Iltis JP, Arrons MC, Castellano GA, Madden DL, Sever JL, Curfman BL, London WT. Simian varicella virus (delta herpesvirus) infection of patas monkeys leading to pneumonia and encephalitis. Proc Soc Exp Biol Med 1982; 169: 266-79.
190. Gray WL, Gusick NJ, Fletcher TM, Soike KF. Simian varicella virus antibody response in experimental infection of African green monkeys. J Med Primatol 1995; 24: 246-51.
191. Gray WL, Williams RJ, Chang R, Soike KF. Experimental simian varicella virus infection of St. Kitts vervet monkeys. J Med Primatol 1998; 27: 177-83.
192. Gray WL. Pathogenesis of simian varicella virus. J Med Virol 2003; 70 (Suppl. 1): S4-8.
193. Ou Y, Davis KA, Traina-Dorge V, Gray WL. Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol 2007; 81: 8149-56.
194. Mahalingam R, Traina-Dorge V, Wellish M, Deharo E, Golilve A, Messaoudi I, Gilden D. Effect of time delay after necropsy on analysis of simian varicella virus expression in latently infected ganglia of rhesus macaques. J Virol 2010; 84: 12454-7.
195. Kolappaswamy K, Mahalingam R, Traina-Dorge V, Shipley ST, Gilden DH, Kleinschmidt-DeMasters BK, McLeod CG Jr, Hungeford LL, DeTolla LJ. Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J Virol 2007; 81: 411-15.
196. Schoeb TR, Eberle R, Black DH, Parker RF, Cartner SC. Diagnostic exercise: papulovesicular dermatitis in rhesus macaques (Macaca mulatta). Vet Pathol 2008; 45: 592-4.
197. Hukkanen RR, Gillen M, Grant R, Liggitt HD, Kiem HP, Kelley ST. Simian varicella virus in pigtailed macaques (Macaca nemestrina): clinical, pathologic, and virologic features. Comp Med 2009; 59: 482-7.
198. Murnane R, Zhang XB, Hukkanen RR, Vogel K, Kelley S, Kiem HP. Myelodysplasia in 2 pig-trained macaques (Macaca nemestrina) associated with retroviral vector-mediated insertional mutagenesis and overexpression of HOXB4. Vet Pathol 2010; [Epub ahead of print] doi: 10.1177/0300985810382673.
199. Myers MG, Stanberry LR, Edmond BJ. Varicella-zoster virus infection of strain 2 guinea pigs. J Infect Dis 1985; 151: 106-13.
200. Pavan-Langston D, Dunkel EC. Ocular varicella-zoster virus infection in the guinea pig: a new in vivo model. Arch Ophthalmol 1989; 107: 1058-72.
201. Myers MG, Connelly BL, Stanberry LR. Varicella in hairless guinea pigs. J Infect Dis 1991; 163: 746-51.
202. Sato H, Pesnicak L, Cohen JI. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency. J Med Virol 2003; 70 (Suppl. 1): S79-81.